We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors focused on the Medical space have likely heard of West Pharmaceutical Services (WST - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
West Pharmaceutical Services is a member of our Medical group, which includes 931 different companies and currently sits at #14 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. WST is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for WST's full-year earnings has moved 5.97% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, WST has gained about 87.54% so far this year. In comparison, Medical companies have returned an average of 0.33%. This means that West Pharmaceutical Services is outperforming the sector as a whole this year.
Looking more specifically, WST belongs to the Medical - Dental Supplies industry, which includes 22 individual stocks and currently sits at #189 in the Zacks Industry Rank. Stocks in this group have gained about 11.62% so far this year, so WST is performing better this group in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track WST. The stock will be looking to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?
Investors focused on the Medical space have likely heard of West Pharmaceutical Services (WST - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
West Pharmaceutical Services is a member of our Medical group, which includes 931 different companies and currently sits at #14 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. WST is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for WST's full-year earnings has moved 5.97% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, WST has gained about 87.54% so far this year. In comparison, Medical companies have returned an average of 0.33%. This means that West Pharmaceutical Services is outperforming the sector as a whole this year.
Looking more specifically, WST belongs to the Medical - Dental Supplies industry, which includes 22 individual stocks and currently sits at #189 in the Zacks Industry Rank. Stocks in this group have gained about 11.62% so far this year, so WST is performing better this group in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track WST. The stock will be looking to continue its solid performance.